-
Canadian Company's New Version Of Chemo-Induced Pain Treatment Is On FDA Track
Tuesday, October 25, 2022 - 1:47pm | 535Drug delivery company IntelGenx Corp. (OTCQB: IGXT)’s development candidate buprenorphine buccal film, for which an Abbreviated New Drug Application (ANDA) has been filed by Chemo Research SL through its agent and affiliate generic pharma products company Xiromed LLC (the US division of Insud...